A compound that inhibits enzymes that act as stop signs for genes counteracts the movement disorders brought on by Huntington's disease, a mouse study suggests.

In this hereditary disease, a genetic mutation results in oversized versions of the so-called huntingtin protein, portions of which stack up in the nuclei of brain cells. Patients develop impairments of thought, movement, and emotions for which there is no treatment or cure.